These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24139596)

  • 1. Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood.
    Colombatti R; Perrotta S; Samperi P; Casale M; Masera N; Palazzi G; Sainati L; Russo G;
    Orphanet J Rare Dis; 2013 Oct; 8():169. PubMed ID: 24139596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.
    Russo G; De Franceschi L; Colombatti R; Rigano P; Perrotta S; Voi V; Palazzi G; Fidone C; Quota A; Graziadei G; Pietrangelo A; Pinto V; Ruffo GB; Sorrentino F; Venturelli D; Casale M; Ferrara F; Sainati L; Cappellini MD; Piga A; Maggio A; Forni GL
    Orphanet J Rare Dis; 2019 May; 14(1):120. PubMed ID: 31146777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action.
    Colombatti R; Martella M; Cattaneo L; Viola G; Cappellari A; Bergamo C; Azzena S; Schiavon S; Baraldi E; Dalla Barba B; Trafojer U; Corti P; Uggeri M; Tagliabue PE; Zorloni C; Bracchi M; Biondi A; Basso G; Masera N; Sainati L
    Pediatr Blood Cancer; 2019 May; 66(5):e27657. PubMed ID: 30724025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodology.
    Green NS; Zapfel A; Nnodu OE; Franklin P; Tubman VN; Chirande L; Kiyaga C; Chunda-Liyoka C; Awuonda B; Ohene-Frempong K; Inusa BPD; Ware RE; Odame I; Ambrose EE; Dogara LG; Oron AP; Willett C; Thompson AA; Berliner N; Coetzer TL; Novelli EM
    Blood Adv; 2022 Dec; 6(24):6187-6197. PubMed ID: 36264096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New ASH initiatives to improve patient care in the long-overlooked sickle cell disease.
    Tubman VN; Mohandas N; Abrams CS
    Blood; 2023 Jul; 142(3):230-234. PubMed ID: 37216689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newborn screening for sickle cell disease: an innovative pilot program to improve child survival in Dar es Salaam, Tanzania.
    Nkya S; Mtei L; Soka D; Mdai V; Mwakale PB; Mrosso P; Mchoropa I; Rwezaula S; Azayo M; Ulenga N; Ngido M; Cox SE; D'Mello BS; Masanja H; Kabadi GS; Mbuya F; Mmbando B; Daniel Y; Streetly A; Killewo J; Tluway F; Lyimo M; Makani J
    Int Health; 2019 Nov; 11(6):589-595. PubMed ID: 31145786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caring for Africa's sickle cell children: will we rise to the challenge?
    Oron AP; Chao DL; Ezeanolue EE; Ezenwa LN; Piel FB; Ojogun OT; Uyoga S; Williams TN; Nnodu OE
    BMC Med; 2020 Apr; 18(1):92. PubMed ID: 32340612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Newborn screening for sickle cell disease in France].
    Brousse V; Allaf B; Benkerrou M
    Med Sci (Paris); 2021 May; 37(5):482-490. PubMed ID: 34003094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting.
    Alvarez OA; Hustace T; Voltaire M; Mantero A; Liberus U; Saint Fleur R
    Pediatrics; 2019 Oct; 144(4):. PubMed ID: 31530717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.
    Colombatti R; Palazzi G; Masera N; Notarangelo LD; Bonetti E; Samperi P; Barone A; Perrotta S; Facchini E; Miano M; Del Vecchio GC; Guerzoni ME; Corti P; Menzato F; Cesaro S; Casale M; Rigano P; Forni GL; Russo G; Sainati L;
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28868627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood cancer in Italy: background, goals, and achievements of the Italian Paediatric Hematology Oncology Association (AIEOP).
    Zecca M; Ferrari A; Quarello P; Rabusin M; Balduzzi A; Buldini B; Rostagno E; Prete A; Favre C; Massimino M; Biondi A; Porta F; Biffi A; Locatelli F; Pession A; Fagioli F
    Tumori; 2021 Oct; 107(5):370-375. PubMed ID: 33876662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis.
    Kuznik A; Habib AG; Munube D; Lamorde M
    BMC Health Serv Res; 2016 Jul; 16():304. PubMed ID: 27461265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.
    Odame I
    Am J Prev Med; 2010 Apr; 38(4 Suppl):S571-5. PubMed ID: 20331960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of sickle cell pain in the emergency department: a priority for health systems.
    Po' C; Colombatti R; Cirigliano A; Da Dalt L; Agosto C; Benini F; Zanconato S; Sainati L
    Clin J Pain; 2013 Jan; 29(1):60-3. PubMed ID: 22751027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newborn Screening for Sickle Cell Disease in Liberia: A Pilot Study.
    Tubman VN; Marshall R; Jallah W; Guo D; Ma C; Ohene-Frempong K; London WB; Heeney MM
    Pediatr Blood Cancer; 2016 Apr; 63(4):671-6. PubMed ID: 26739520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017.
    Su ZT; Segal JB; Lanzkron S; Ogunsile FJ
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1246-1250. PubMed ID: 31328369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle cell disease in sub-Saharan Africa: stakes and strategies for control of the disease.
    Diallo DA; Guindo A
    Curr Opin Hematol; 2014 May; 21(3):210-4. PubMed ID: 24613937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research.
    Campbell AD; Colombatti R; Andemariam B; Strunk C; Tartaglione I; Piccone CM; Manwani D; Asare EV; Boruchov D; Farooq F; Urbonya R; Boatemaa GD; Perrotta S; Sainati L; Rivers A; Rao S; Zempsky W; Sey F; Segbefia C; Inusa B; Antwi-Boasiako C
    J Racial Ethn Health Disparities; 2021 Feb; 8(1):99-106. PubMed ID: 32418182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-third of the new paediatric patients with sickle cell disease in The Netherlands are immigrants and do not benefit from neonatal screening.
    Peters M; Fijnvandraat K; van den Tweel XW; Garre FG; Giordano PC; van Wouwe JP; Pereira RR; Verkerk PH
    Arch Dis Child; 2010 Oct; 95(10):822-5. PubMed ID: 20576657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.